Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Clinical trial NCT03220009 · WITHDRAWN

Trial details

NCT number: NCT03220009
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Carcinoma Esophageal Carcinoma Mucosal Melanoma Mucosal Melanoma of the Head and Neck Oral Cavity Mucosal Melanoma Recurrent Melanoma Stage II Vulvar Cancer AJCC v7 Stage III Vulvar Cancer AJCC v7 Stage IIIA Vulvar Cancer AJCC v7 Stage IIIB Vulvar Cancer AJCC v7 Stage IIIC Vulvar Cancer AJCC v7 Stage IV Oral Cavity Cancer AJCC v6 and v7

Start date: 2017-11-03
Primary completion: 2021-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.